Cruzain-IN-1 |
An inhibitor of cruzain (IC50 = 0.2 nM); selective for cruzain over cathep… |
25 mg |
37350-25 |
More Info
|
Cruzain-IN-1 |
An inhibitor of cruzain (IC50 = 0.2 nM); selective for cruzain over cathep… |
5 mg |
37350-5 |
More Info
|
Cryogenine |
An alkaloid with anti-inflammatory activity; inhibits prostaglandin synthe… |
1 mg |
25287-1 |
More Info
|
Cryogenine |
An alkaloid with anti-inflammatory activity; inhibits prostaglandin synthe… |
10 mg |
25287-10 |
More Info
|
Cryogenine |
An alkaloid with anti-inflammatory activity; inhibits prostaglandin synthe… |
5 mg |
25287-5 |
More Info
|
Cryptochlorogenic Acid |
A phenolic acid with diverse biological activities; inhibits RLAR in vitro… |
10 mg |
25098-10 |
More Info
|
Cryptochlorogenic Acid |
A phenolic acid with diverse biological activities; inhibits RLAR in vitro… |
100 mg |
25098-100 |
More Info
|
Cryptochlorogenic Acid |
A phenolic acid with diverse biological activities; inhibits RLAR in vitro… |
50 mg |
25098-50 |
More Info
|
(-)-Cryptopleurine |
An alkaloid; inhibits the growth of human A375, A431, A549, MES-SA, and MC… |
1 mg |
31642-1 |
More Info
|
(-)-Cryptopleurine |
An alkaloid; inhibits the growth of human A375, A431, A549, MES-SA, and MC… |
5 mg |
31642-5 |
More Info
|
Cryptotanshinone |
A natural quinoid diterpene that, at 10-20 µM, stimulates AMPK in C2… |
10 mg |
16987-10 |
More Info
|
Cryptotanshinone |
A natural quinoid diterpene that, at 10-20 µM, stimulates AMPK in C2… |
25 mg |
16987-25 |
More Info
|
Cryptotanshinone |
A natural quinoid diterpene that, at 10-20 µM, stimulates AMPK in C2… |
5 mg |
16987-5 |
More Info
|
Cryptotanshinone |
A natural quinoid diterpene that, at 10-20 µM, stimulates AMPK in C2… |
50 mg |
16987-50 |
More Info
|
CS2164 |
A multi-kinase inhibitor; inhibits VEGFR1, -2, and -3 (IC50s = 8, 7, and 9… |
10 mg |
38766-10 |
More Info
|
CS2164 |
A multi-kinase inhibitor; inhibits VEGFR1, -2, and -3 (IC50s = 8, 7, and 9… |
25 mg |
38766-25 |
More Info
|
CS2164 |
A multi-kinase inhibitor; inhibits VEGFR1, -2, and -3 (IC50s = 8, 7, and 9… |
5 mg |
38766-5 |
More Info
|
C16 (2'(S)-hydroxy) Ceramide (d18:1/16:0) |
A synthetic ceramide; has no effect on C6 glioma cell viability at concent… |
1 mg |
22516-1 |
More Info
|
C16 (2'(S)-hydroxy) Ceramide (d18:1/16:0) |
A synthetic ceramide; has no effect on C6 glioma cell viability at concent… |
10 mg |
22516-10 |
More Info
|
C16 (2'(S)-hydroxy) Ceramide (d18:1/16:0) |
A synthetic ceramide; has no effect on C6 glioma cell viability at concent… |
25 mg |
22516-25 |
More Info
|
C16 (2'(S)-hydroxy) Ceramide (d18:1/16:0) |
A synthetic ceramide; has no effect on C6 glioma cell viability at concent… |
5 mg |
22516-5 |
More Info
|
C24 (2'(S)-hydroxy) Ceramide (d18:1/24:0) |
A ceramide; has been found in D. lenticellatum |
1 mg |
22526-1 |
More Info
|
C24 (2'(S)-hydroxy) Ceramide (d18:1/24:0) |
A ceramide; has been found in D. lenticellatum |
5 mg |
22526-5 |
More Info
|
C24 (2'(S)-hydroxy) dihydro Ceramide (d18:0/24:0) |
A hydroxylated dihydro ceramide |
1 mg |
28936-1 |
More Info
|
C24 (2'(S)-hydroxy) Phytoceramide (t18:0/24:0) |
A sphingolipid |
1 mg |
28934-1 |
More Info
|
C16 Sphingomyelin-13C (d18:1/16:0-13C) |
An internal standard for the quantification of C16sphingomyelin by GC- or… |
1 mg |
24452-1 |
More Info
|
C16 Sphingomyelin (d18:1/16:0) |
A naturally occurring sphingolipid; levels are elevated in the prefrontal… |
1 mg |
10007946-1 |
More Info
|
C16 Sphingomyelin (d18:1/16:0) |
A naturally occurring sphingolipid; levels are elevated in the prefrontal… |
10 mg |
10007946-10 |
More Info
|
C16 Sphingomyelin (d18:1/16:0) |
A naturally occurring sphingolipid; levels are elevated in the prefrontal… |
5 mg |
10007946-5 |
More Info
|
C17 Sphingomyelin (d18:1/17:0) |
A synthetic derivative of sphingomyelin; has been used as an internal stan… |
10 mg |
25592-10 |
More Info
|
C17 Sphingomyelin (d18:1/17:0) |
A synthetic derivative of sphingomyelin; has been used as an internal stan… |
25 mg |
25592-25 |
More Info
|
C17 Sphingomyelin (d18:1/17:0) |
A synthetic derivative of sphingomyelin; has been used as an internal stan… |
5 mg |
25592-5 |
More Info
|
C18 Sphingomyelin (d18:1/18:0) |
A bioactive sphingolipid; naturally occurring form of sphingomyelin; incre… |
5 mg |
24355-5 |
More Info
|
C2 Sphingomyelin (d18:1/2:0) |
A synthetic cell-permeable derivative of sphingomyelin; a mixture of the D… |
5 mg |
24353-5 |
More Info
|
C20 Sphingomyelin (d18:1/20:0) |
A sphingolipid; upregulated in the hippocampus of rats with streptozotocin… |
500 µg |
24450-500 |
More Info
|
C22 Sphingomyelin (d18:1/22:0) |
A sphingolipid; plasma levels correlate with hepatic steatosis severity in… |
500 µg |
24451-500 |
More Info
|
C26 Sphingomyelin (d18:1/26:0) |
A sphingolipid that has been found in serum and cell or brain extracts; le… |
1 mg |
9003457-1 |
More Info
|
C26 Sphingomyelin (d18:1/26:0) |
A sphingolipid that has been found in serum and cell or brain extracts; le… |
5 mg |
9003457-5 |
More Info
|
C26 Sphingomyelin (d18:1/26:0) |
A sphingolipid that has been found in serum and cell or brain extracts; le… |
500 µg |
9003457-500 |
More Info
|
C16 Sphingomyelin-d9 (d18:1/16:0-d9) |
An internal standard for the quantification of C16 sphingomyelin by GC- or… |
1 mg |
27551-1 |
More Info
|
C16 Sphingomyelin-d9 (d18:1/16:0-d9) |
An internal standard for the quantification of C16 sphingomyelin by GC- or… |
500 µg |
27551-500 |
More Info
|
C26 Sphingomyelin-d4 (d18:1/26:0-d4) |
An internal standard for the quantification of C26 sphingomyelin by GC- or… |
1 mg |
9003460-1 |
More Info
|
C26 Sphingomyelin-d4 (d18:1/26:0-d4) |
An internal standard for the quantification of C26 sphingomyelin by GC- or… |
500 µg |
9003460-500 |
More Info
|
C26:1 Sphingomyelin-d5 (d18:1/26:1(17Z)-d5) |
An internal standard for the quantification of C26:1 sphingomyelin by GC-… |
1 mg |
9003463-1 |
More Info
|
C26:1 Sphingomyelin-d5 (d18:1/26:1(17Z)-d5) |
An internal standard for the quantification of C26:1 sphingomyelin by GC-… |
500 µg |
9003463-500 |
More Info
|
C26:1 Sphingomyelin (d18:1/26:1(17Z)) |
A naturally occurring sphingolipid; has been found in human aqueous humor |
1 mg |
9003459-1 |
More Info
|
C26:1 Sphingomyelin (d18:1/26:1(17Z)) |
A naturally occurring sphingolipid; has been found in human aqueous humor |
500 µg |
9003459-500 |
More Info
|
C12-SPM |
A polyamine branched-chain lipidoid; has been used in combination with oth… |
10 mg |
38784-10 |
More Info
|
C12-SPM |
A polyamine branched-chain lipidoid; has been used in combination with oth… |
25 mg |
38784-25 |
More Info
|
C12-SPM |
A polyamine branched-chain lipidoid; has been used in combination with oth… |
5 mg |
38784-5 |
More Info
|
C14-SPM |
A polyamine branched-chain lipidoid; has been used in combination with oth… |
10 mg |
38785-10 |
More Info
|
C14-SPM |
A polyamine branched-chain lipidoid; has been used in combination with oth… |
25 mg |
38785-25 |
More Info
|
C14-SPM |
A polyamine branched-chain lipidoid; has been used in combination with oth… |
5 mg |
38785-5 |
More Info
|
C12 3'-sulfo Galactosylceramide (d18:1/12:0) |
A sulfatide; has been used as an internal standard for the quantification… |
1 mg |
24349-1 |
More Info
|
C16 3'-sulfo Galactosylceramide (d18:1/16:0) |
A sulfatide; inhibits retinal ganglion cell neurite outgrowth in vitro; ha… |
1 mg |
24862-1 |
More Info
|
C17 3'-sulfo Galactosylceramide (d18:1/17:0) |
A synthetic sulfatide; has been used as an internal standard for the quant… |
1 mg |
24348-1 |
More Info
|
C18 3'-sulfo Galactosylceramide (d18:1/18:0) |
A sulfatide; a minor endogenous sphingolipid; levels are increased in brai… |
1 mg |
24863-1 |
More Info
|
C19 3'-sulfo Galactosylceramide (d18:1/19:0) |
A synthetic derivative of sulfatide |
1 mg |
24866-1 |
More Info
|
C2 3'-sulfo Galactosylceramide (d18:1/2:0) |
A sulfatide; has been used as an internal standard in the quantification o… |
1 mg |
24861-1 |
More Info
|
C24 3'-sulfo Galactosylceramide (d18:1/24:0) |
An endogenous sulfatide; the major sulfatide in mature myelin in the centr… |
1 mg |
24351-1 |
More Info
|
C18 3'-sulfo Galactosylceramide-d3 (d18:1/18:0-d3) |
An internal standard for the quantification of C18 3'-sulfo galactosylcera… |
1 mg |
24624-1 |
More Info
|
C18:1 3'-sulfo Galactosylceramide (d18:1/18:1(9Z)) |
A sulfatide; has been found in mouse brain; has been used as a standard fo… |
1 mg |
24864-1 |
More Info
|
C24:1 3'-sulfo Galactosylceramide (d18:1/24:1(15Z)) |
A sulfatide; interacts with LMIR5 to increase activation of NFAT; an immun… |
1 mg |
24865-1 |
More Info
|
C18 3'-sulfo Lactosylceramide (d18:1/18:0) |
A sulfated glycosphingolipid |
1 mg |
27201-1 |
More Info
|
CT3 |
A cyanotriazole antiparasitic; active against T. b. brucei, T. b. gambiens… |
1 mg |
39416-1 |
More Info
|
CT3 |
A cyanotriazole antiparasitic; active against T. b. brucei, T. b. gambiens… |
5 mg |
39416-5 |
More Info
|
CT3 |
A cyanotriazole antiparasitic; active against T. b. brucei, T. b. gambiens… |
500 µg |
39416-500 |
More Info
|
CTAP (trifluoroacetate salt) |
A water soluble, cyclic octapeptide which acts as a receptor antagonist th… |
1 mg |
14959-1 |
More Info
|
CTB |
An activator of p300; induces acetylation of core histones in HeLa cells a… |
10 mg |
37480-10 |
More Info
|
CTB |
An activator of p300; induces acetylation of core histones in HeLa cells a… |
25 mg |
37480-25 |
More Info
|
CTB |
An activator of p300; induces acetylation of core histones in HeLa cells a… |
5 mg |
37480-5 |
More Info
|
CTB |
An activator of p300; induces acetylation of core histones in HeLa cells a… |
50 mg |
37480-50 |
More Info
|
CTEP |
An inverse agonist of mGluR5 (Kis = 16.4, 12.6, and 9.5 nM for the human,… |
10 mg |
28773-10 |
More Info
|
CTEP |
An inverse agonist of mGluR5 (Kis = 16.4, 12.6, and 9.5 nM for the human,… |
25 mg |
28773-25 |
More Info
|
CTEP |
An inverse agonist of mGluR5 (Kis = 16.4, 12.6, and 9.5 nM for the human,… |
5 mg |
28773-5 |
More Info
|